GGrantIndex
← Search

Research Pharmacy

$103,096P30FY2019CANIH

Rbhs -Cancer Institute Of New Jersey, New Brunswick NJ

Investigators

Linked publications, trials & patents

Trial NCT05639972Trial NCT05483491Trial NCT05296421Trial NCT04929015Trial NCT04920344Trial NCT04871516Trial NCT04751747Trial NCT04445844Trial NCT04294264Trial NCT04285268Trial NCT04253483Trial NCT04211259Trial NCT04179227Trial NCT04163952Trial NCT04146038Trial NCT04081688Trial NCT03902379Trial NCT03725449Trial NCT03677739Trial NCT03456843Trial NCT03448224Trial NCT03441321Trial NCT03428802Trial NCT03272633Trial NCT03257163Trial NCT03233555Trial NCT03229278Trial NCT03228147Trial NCT03112668Trial NCT03108911Trial NCT03102060Trial NCT03061175Trial NCT03028948Trial NCT02949284Trial NCT02885649Trial NCT02748564Trial NCT02699996Trial NCT02688517Trial NCT02688192Trial NCT02621398Trial NCT02526511Trial NCT02526498Trial NCT02458716Trial NCT02421575Trial NCT02420652Trial NCT02324621Trial NCT02324608Trial NCT02315196Trial NCT02295540Trial NCT02294617Trial NCT02250781Trial NCT02203604Trial NCT02203578Trial NCT02177838Trial NCT02144701Trial NCT02144675Trial NCT02105116Trial NCT01828476Trial NCT01694589Trial NCT01652014Trial NCT01649947Trial NCT01480154Trial NCT01417286Trial NCT01407562Trial NCT01303341Trial NCT01251172Trial NCT01032590Trial NCT01018836Trial NCT01009931Trial NCT01006369Trial NCT00996359Trial NCT00991315Trial NCT00966667Trial NCT00962845Trial NCT00946283Trial NCT00943709Trial NCT00939380Trial NCT00934895Trial NCT00909909Trial NCT00905918Trial NCT00900120Trial NCT00899808Trial NCT00899639Trial NCT00895115Trial NCT00891969Trial NCT00878657Trial NCT00866840Trial NCT00853125Trial NCT00813423Trial NCT00786682Trial NCT00770419Trial NCT00770055Trial NCT00769652Trial NCT00765765Trial NCT00749437Trial NCT00740805Trial NCT00728845Trial NCT00726596Trial NCT00669734Trial NCT00667901

Abstract

RESEARCH PHARMACY SHARED RESOURCE PROJECT SUMMARY/ABSTRACT Cancer clinical trials advance treatment paradigms by testing agents for potentially greater efficacy or lesser toxicity. The Research Pharmacy shared resource provides expertise in investigational and commercially available cancer therapeutic agents and ensures a uniformly high standard of safe, accurate treatment for CINJ patients with cancer participating in clinical trials; these services are crucial to one of the central strategic initiatives of the cancer center: high quality, innovative translational research. The Research Pharmacy shared resource of Rutgers Cancer Institute of New Jersey (CINJ) is a Cancer Center managed shared resource whose purpose is to support CINJ members who conduct rigorously reviewed research with investigational agents in human subjects by providing an efficient, centralized service of extraordinary quality. Since the last CCSG submission, Research Pharmacy is increasingly called upon for consultation in the planning of clinical projects. CINJ investigators seek advice on issues regarding drug interactions, drug sequencing for multi-agent trials, dose modifications, formulation of compounds, identification of compounds for use, and consultations regarding Investigational New Drug (IND) applications. Additionally, our Informatics Pharmacist performs various data mining of our electronic medical record (EMR) to assist investigators in selecting and modeling clinical trials based on our patient population. These efforts are guided by policies and procedures ensuring compliance with HIPAA and institutional review board (IRB) requirements.

View original record on NIH RePORTER →